Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NBRVF

Nabriva Therapeutics plc

USD

Set alert

Price alert · NBRVF

All alert types
0.00 USD 0.00 0.00%
As of Oct 29, 2026
0.0001 Day range 0.0001
0.0001 52-week range 0.0002
YTD
0.00%
1 year
0.00%
Open
0.0001
Prev close
0.0001
Mkt cap
323
Vol
780
Avg vol
0
EPS
-18.41
P/E
0.00
More statistics
Low
0.0001
High
0.0001

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NBRVF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-104.97 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.1×
FY 2013: 23.3×FY 2014: -22.1×FY 2015: -7.4×FY 2016: -2.3×FY 2017: -2.6×FY 2018: -0.6×FY 2019: -1.2×FY 2020: -0.4×FY 2021: -0.5×FY 2022: -0.1×
FY 2013 5y median -0.5× FY 2022
P/S 0.1×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 11.4×FY 2019: 12.6×FY 2020: 6.2×FY 2021: 1.0×FY 2022: 0.1×
FY 2013 5y median 6.2× FY 2022
P/B 1.5×
FY 2013: -15.5×FY 2014: -9.8×FY 2015: 2.1×FY 2016: 1.7×FY 2017: 2.3×FY 2018: 1.1×FY 2019: 2.4×FY 2020: 0.9×FY 2021: 0.5×FY 2022: 1.5×
FY 2013 5y median 1.1× FY 2022
P/FCF -0.1×
FY 2013: -69.1×FY 2014: -33.9×FY 2015: -10.6×FY 2016: -2.6×FY 2017: -2.7×FY 2018: -1.0×FY 2019: -1.4×FY 2020: -0.4×FY 2021: -0.4×FY 2022: -0.1×
FY 2013 5y median -0.4× FY 2022
EV/EBITDA 0.0×
FY 2013: 19.1×FY 2014: -39.5×FY 2015: -30.8×FY 2016: -1.8×FY 2017: -1.4×FY 2018: 0.0×FY 2019: -0.6×FY 2020: 0.0×FY 2021: 0.3×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
EV/Sales -0.1×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: -0.6×FY 2019: 6.0×FY 2020: -0.5×FY 2021: -0.5×FY 2022: -0.1×
FY 2013 5y median -0.5× FY 2022
FCF Yield -728.4%
FY 2013: -1.4%FY 2014: -2.9%FY 2015: -9.4%FY 2016: -39.0%FY 2017: -37.2%FY 2018: -98.4%FY 2019: -73.5%FY 2020: -229.8%FY 2021: -229.5%FY 2022: -728.4%
FY 2013 5y median -229.5% FY 2022

Profitability

Gross Margin 19.9%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: 99.1%FY 2020: 68.5%FY 2021: 51.7%FY 2022: 19.9%
FY 2013 5y median 68.5% FY 2022
Operating Margin -155.6%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -1759.6%FY 2019: -1025.9%FY 2020: -1315.4%FY 2021: -178.3%FY 2022: -155.6%
FY 2013 5y median -1025.9% FY 2022
Net Margin -160.3%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -1765.8%FY 2019: -1068.2%FY 2020: -1382.2%FY 2021: -181.7%FY 2022: -160.3%
FY 2013 5y median -1068.2% FY 2022
ROE -1736.6%
FY 2013: -66.6%FY 2014: 44.4%FY 2015: -28.9%FY 2016: -71.0%FY 2017: -90.6%FY 2018: -167.2%FY 2019: -200.5%FY 2020: -209.7%FY 2021: -92.7%FY 2022: -1736.6%
FY 2013 5y median -200.5% FY 2022
ROIC -617.0%
FY 2013: -537.5%FY 2014: 141.1%FY 2015: -21.7%FY 2016: -70.3%FY 2017: -89.4%FY 2018: -123.5%FY 2019: -102.6%FY 2020: -157.6%FY 2021: -77.9%FY 2022: -617.0%
FY 2013 5y median -123.5% FY 2022
ROA -180.0%
FY 2013: 210.6%FY 2014: -337.6%FY 2015: -26.6%FY 2016: -58.9%FY 2017: -77.6%FY 2018: -104.0%FY 2019: -87.9%FY 2020: -118.9%FY 2021: -61.1%FY 2022: -180.0%
FY 2013 5y median -104.0% FY 2022

Growth (YoY)

Revenue 31.1%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 19.2%FY 2020: -35.1%FY 2021: 441.4%FY 2022: 31.1%
FY 2013 FY 2022
Operating Income -14.3%
FY 2013: 0.0%FY 2014: 27.8%FY 2015: -145.5%FY 2016: -129.6%FY 2017: -34.0%FY 2018: -55.0%FY 2019: 30.5%FY 2020: 16.8%FY 2021: 26.6%FY 2022: -14.3%
FY 2013 FY 2022
EPS (diluted) 25.2%
FY 2013: 0.0%FY 2014: -205.1%FY 2015: -116.9%FY 2016: -97.0%FY 2017: 2.5%FY 2018: 9.3%FY 2019: 50.7%FY 2020: 51.5%FY 2021: 78.9%FY 2022: 25.2%
FY 2013 FY 2022
Free Cash Flow 38.0%
FY 2013: 0.0%FY 2014: -103.7%FY 2015: -106.5%FY 2016: -127.8%FY 2017: -41.3%FY 2018: -3.4%FY 2019: 1.4%FY 2020: 0.7%FY 2021: 16.6%FY 2022: 38.0%
FY 2013 FY 2022

Financial Health

Current Ratio 1.1×
FY 2013: 0.3×FY 2014: 0.1×FY 2015: 12.5×FY 2016: 5.7×FY 2017: 7.1×FY 2018: 6.1×FY 2019: 5.5×FY 2020: 3.1×FY 2021: 3.6×FY 2022: 1.1×
FY 2013 5y median 3.6× FY 2022
Quick Ratio 0.8×
FY 2013: 0.3×FY 2014: 0.1×FY 2015: 12.5×FY 2016: 5.7×FY 2017: 7.1×FY 2018: 6.1×FY 2019: 5.4×FY 2020: 2.8×FY 2021: 2.9×FY 2022: 0.8×
FY 2013 5y median 2.9× FY 2022
Debt / Equity 1.6×
FY 2013: -0.7×FY 2014: -0.7×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.3×FY 2019: 0.8×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 1.6×
FY 2013 5y median 0.3× FY 2022
Net Debt / EBITDA 0.1×
FY 2013: 0.6×FY 2014: -2.5×FY 2015: 5.7×FY 2016: 0.6×FY 2017: 1.2×FY 2018: 0.7×FY 2019: 0.7×FY 2020: 0.5×FY 2021: 0.8×FY 2022: 0.1×
FY 2013 5y median 0.7× FY 2022
Interest Coverage -79.5×
FY 2013: -2.4×FY 2014: -1.4×FY 2015: -1.6×FY 2016: -734×FY 2017: -1716×FY 2018: -860×FY 2019: -21.8×FY 2020: -38.1×FY 2021: -53.9×FY 2022: -79.5×
FY 2013 5y median -53.9× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31